COKE
Coca-Cola Consolidated, Inc.
COKE's fundamentals are mixed, but it looks expensive: trading at 24x earnings, above its usual 21x.
COKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
COKE's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
COKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $126 | -39% |
| Fair | 21x | $176 | -15% |
| Current | 24x | $207 | — |
| Expensive | 26x | $224 | +8.4% |
Historical ranges are pointers, not guarantees.
COKE's PE is in its expensive range at 24x.
COKE Forward outlook
There aren't enough analyst estimates for COKE to show an outlook.
COKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $8.53 | +21% |
| Q2 2026 | $7.53 | +12% |
| Q1 2026 | $7.30 | +14% |
| Q4 2025 | $6.82 | +0.1% |
| Q3 2025 | $7.03 | +26% |
| Q2 2025 | $6.71 | +28% |
| Q1 2025 | $6.41 | +37% |
| Q4 2024 | $6.81 | +57% |
COKE's earnings per share have climbed steadily: $8.53 over the past year, up 21% from the year before, and higher year over year for 10 quarters in a row.
COKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +5.4% |
| Q2 2026 | $2.1B | +11% |
| Q1 2026 | $1.8B | +17% |
| Q4 2025 | $1.9B | +9% |
| Q3 2025 | $1.9B | +6.9% |
| Q2 2025 | $1.9B | +3.3% |
| Q1 2025 | $1.6B | -0.7% |
| Q4 2024 | $1.7B | +7.1% |
COKE's revenue has grown year over year for six quarters in a row: $2B last quarter, up 5.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +0.6 points |
| Q2 2026 | 13% | -1.4 points |
| Q1 2026 | 13% | +0.8 points |
| Q4 2025 | 13% | +0.4 points |
| Q3 2025 | 13% | +0.2 points |
| Q2 2025 | 15% | +0.2 points |
| Q1 2025 | 12% | -1.5 points |
| Q4 2024 | 13% | +1.6 points |
COKE's operating margin was 14% last quarter, up 0.6 points from the same quarter a year ago.
COKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $172.2M | -35% |
| Q2 2026 | $131.1M | -12% |
| Q1 2026 | $142.2M | +42% |
| Q4 2025 | $107.3M | +27% |
| Q3 2025 | $264.1M | +85% |
| Q2 2025 | $148.5M | -7.5% |
| Q1 2025 | $100.3M | -14% |
| Q4 2024 | $84.8M | +135% |
COKE generated $553M in free cash flow over the past year, down 7.5% from the year before.
COKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.8x | Healthy |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 0.8x | Very low |
COKE's net debt is about 1.8 years of its operating earnings (EBITDA), up from less than a year a year ago.
COKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.5 | Neutral |
| Stochastic | 75.8 | Neutral |
COKE's weekly RSI is 60 (neutral) and its Stochastic is 76 (neutral).
COKE PE vs Consumer Defensive Sector
| Metric | COKE | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 19x | 25% above |
| PE % | 70 | 18 | 52 pts above |
COKE is trading at 24x earnings, a 25% premium to the Consumer Defensive sector's median of 19x.
COKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $202.2 | 2.4% above |
| 20 week MA | $194.5 | 6.4% above |
| 50 week MA | $184.6 | 12% above |
| 100 week MA | $155.5 | 33% above |
| 200 week MA | $120.3 | 72% above |
COKE is in an uptrend: it's above all five of its weekly moving averages, and 72% above its 200-week average.
COKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.4 | $26.6 | -9.4% |
| 2021 | $26.6 | $59.4 | +123% |
| 2022 | $59.4 | $52.3 | -12% |
| 2023 | $52.3 | $92.8 | +78% |
| 2024 | $92.8 | $123.2 | +33% |
| 2025 | $123.2 | $160.6 | +30% |
| 2026 YTD | $160.6 | $207.0 | +29% |
COKE has finished higher in four of the last six years, two of them by more than 50%. It's up 29% so far in 2026.